ABII » Topics » PAYMENTS UPON TERMINATION

This excerpt taken from the ABII DEF 14A filed Oct 30, 2009.

PAYMENTS UPON TERMINATION

This section describes the payments and benefits that certain of our named executive officers would have been entitled to had their employment been terminated under the circumstances described below on December 31, 2008. In this section, the value associated with the acceleration of equity compensation is based on the closing market price of a share of our common stock as of December 31, 2008 minus the exercise price. On December 31, 2008, the closing market price of our common stock was $68.77. The amounts also include those amounts that the executive earned through that time and estimated amounts that would be paid out upon termination. The actual payments to the executive can only be determined at the actual time of termination.

David O’Toole and Edward Geehr

Mr. O’Toole’s and Dr. Geehr’s employment agreements provide for severance benefits in the event that the executive’s employment is terminated (i) by the company without cause or (ii) by the executive for “Good Reason.” Severance benefits are specifically not triggered by a termination of employment in the event of a “sale transaction” where the agreement is specifically assumed by the successor entity. If severance benefits are triggered, the executive will receive (in addition to his salary up to the termination date, accrued vacation and other vested benefits under company benefit plans up to the date of termination) the sum of the following over a twelve month period from the date of termination (the “Severance Period”), subject to restrictions under Section 409A of the Code, (i) 150% of the executives salary based on his then-current base salary and (ii) a bonus (if applicable) calculated based generally on either the 2009 target incentive bonus (if the termination occurs before the 2009 bonus is paid) or the average of the last two annual incentive bonuses paid, and in either case, prorated to the date of termination. In addition, any stock options and other equity awards held by the executive would accelerate up to the end of the Severance Period. These severance payments and benefits are contingent on the executive agreeing not to compete with the company during the Severance Period and

 

24


executing a general release in favor of the company. Under their employment agreements, these severance payments would equal $800,000 for Mr. O’Toole and $850,000 for Dr. Geehr, assuming the executives’ current base salaries, a target bonus of 50% of base salary (with no proration), and not including a value for the acceleration of any equity holdings.

For purposes of these agreements, the term “cause” included:

 

   

a material breach of the agreement, confidentiality agreement or any policy of the company is not cured to our satisfaction within twenty (20) days after written notice to Executive from us;

 

   

the failure of the executive to substantially perform her duties that continues for 20 days following notice;

 

   

the indictment of a crime involving dishonesty, breach of trust, physical harm to any person or serious moral turpitude; or

 

   

the engagement of in conduct that is materially injurious to the Company (monetarily or otherwise) or that constitutes a material violation of federal or state law relating to the Company or its business.

The term “good reason” included the occurrence any of the following without the executive’s express consent:

 

   

a material adverse change to his overall status and responsibility in our company;

 

   

he is required to be based at any place outside of fifty (50) miles from our current principal office;

 

   

a reduction in his base salary or benefits; or

 

   

any failure by the successor to the company to assume and agree to perform the company’s obligations hereunder.

Mr. O’Toole and Dr. Geehr resigned their employment with us in July 2009 and August 2009, respectively. Under the terms of agreements that we entered into with them at the time, we made a severance payment to Mr. O’Toole and Dr. Geehr in the amount of $800,000, and $668,000, respectively, less applicable withholding amounts. In addition, the equity awards that Mr. O’Toole and Dr. Geehr received during their employment accelerated for an additional twelve months following the termination date

Lisa Gopala

Ms. Gopala resigned her employment with us effective May 21, 2008. Under the terms of an agreement that we entered into with Ms. Gopala at the time, we paid her as a severance payment of $868,750, less applicable withholding amounts. In addition, the stock options that Ms. Gopala received in connection with her employment agreement accelerated for an additional eighteen months following the termination date; however, she did not exercise any of such options prior to their expiration.

 

25


These excerpts taken from the ABII 10-K filed Apr 30, 2009.

PAYMENTS UPON TERMINATION

This section describes the payments and benefits that certain of our named executive officers would have been entitled to had their employment been terminated under the circumstances described below on December 31, 2008. In this section, the value associated with the acceleration of equity compensation is based on the closing market price of a share of our common stock as of December 31, 2008 minus the exercise price (if any). On December 31, 2008, the closing market price of our common stock was $68.77. The amounts also include those amounts that the executive earned through that time and estimated amounts that would be paid out upon termination. The actual payments to the executive can only be determined at the actual time of termination.

David O’Toole and Edward Geehr

Mr. O’Toole’s and Dr. Geehr’s employment agreements provide for severance benefits in the event that the executive’s employment is terminated (i) by the company without cause, or (ii) by the executive for “Good Reason.” Severance benefits are specifically not triggered by a termination of employment in the event of a “sale transaction” where the agreement is specifically assumed by the successor entity. If severance benefits are triggered, the executive will receive (in addition to his salary up to the termination date, accrued vacation, and other vested benefits under company benefit plans up to the date of termination) the sum of the following over a twelve month period from the date of termination (the “Severance Period”), subject to restrictions under Section 409A of the Code, (i) 150% of the executive’s salary based on his then-current base salary, and (ii) a bonus (if applicable) calculated based on either the 2009 target incentive bonus (if the termination occurs before the 2009 bonus is paid) or the average of the last two annual incentive bonuses paid, and in either case, prorated to the date of termination. In

 

16


addition, any stock options and other equity awards held by the executive would accelerate up to the end of the Severance Period. These severance payments and benefits are contingent on the executive agreeing not to compete with the company during the Severance Period and executing a general release in favor of the company. Under their employment agreements, these severance payments would equal $800,000 for Mr. O’Toole and $850,000 for Dr. Geehr, assuming the executives’ current base salaries, a target bonus of 50% of base salary (with no proration), and not including a value for the acceleration of any equity holdings.

For purposes of these agreements, the term “cause” included:

 

   

a material breach of the agreement, confidentiality agreement or any of our policies, if not cured to our satisfaction within twenty (20) days after our written notice to Executive;

 

   

the failure of the executive to substantially perform his duties, which continues for 20 days following notice;

 

   

the indictment of a crime involving dishonesty, breach of trust, physical harm to any person or serious moral turpitude; or

 

   

the engagement of conduct which is materially injurious to us (monetarily or otherwise) or which constitutes a material violation of federal or state law relating to us or our business.

The term “good reason” included the occurrence any of the following without the executive’s express consent:

 

   

a material adverse change to his overall status and responsibility;

 

   

requiring him to be based at any place outside of fifty (50) miles from our current principal office;

 

   

a reduction in his base salary or benefits; or

 

   

any failure by a successor company to assume and agree to perform our obligations hereunder.

Lisa Gopala

Ms. Gopala resigned her employment with us effective May 21, 2008. Under the terms of an agreement that we entered into with Ms. Gopala at the time, we paid her a severance payment of $868,750, less applicable withholding amounts. In addition, the stock options that Ms. Gopala received in connection with her employment agreement accelerated their vesting for an additional eighteen months following the termination date; however, she did not exercise any of such options prior to their expiration date.

PAYMENTS UPON
TERMINATION

This section describes the payments and benefits that certain of our named executive officers would have been entitled to
had their employment been terminated under the circumstances described below on December 31, 2008. In this section, the value associated with the acceleration of equity compensation is based on the closing market price of a share of our common
stock as of December 31, 2008 minus the exercise price (if any). On December 31, 2008, the closing market price of our common stock was $68.77. The amounts also include those amounts that the executive earned through that time and
estimated amounts that would be paid out upon termination. The actual payments to the executive can only be determined at the actual time of termination.

FACE="Times New Roman" SIZE="2">David O’Toole and Edward Geehr

Mr. O’Toole’s and Dr. Geehr’s
employment agreements provide for severance benefits in the event that the executive’s employment is terminated (i) by the company without cause, or (ii) by the executive for “Good Reason.” Severance benefits are
specifically not triggered by a termination of employment in the event of a “sale transaction” where the agreement is specifically assumed by the successor entity. If severance benefits are triggered, the executive will receive (in
addition to his salary up to the termination date, accrued vacation, and other vested benefits under company benefit plans up to the date of termination) the sum of the following over a twelve month period from the date of termination (the
“Severance Period”), subject to restrictions under Section 409A of the Code, (i) 150% of the executive’s salary based on his then-current base salary, and (ii) a bonus (if applicable) calculated based on either the 2009
target incentive bonus (if the termination occurs before the 2009 bonus is paid) or the average of the last two annual incentive bonuses paid, and in either case, prorated to the date of termination. In

 


16









addition, any stock options and other equity awards held by the executive would accelerate up to the end of the Severance Period. These severance payments
and benefits are contingent on the executive agreeing not to compete with the company during the Severance Period and executing a general release in favor of the company. Under their employment agreements, these severance payments would equal
$800,000 for Mr. O’Toole and $850,000 for Dr. Geehr, assuming the executives’ current base salaries, a target bonus of 50% of base salary (with no proration), and not including a value for the acceleration of any equity holdings.

For purposes of these agreements, the term “cause” included:

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

a material breach of the agreement, confidentiality agreement or any of our policies, if not cured to our satisfaction within twenty (20) days after our
written notice to Executive;

 







  

the failure of the executive to substantially perform his duties, which continues for 20 days following notice;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

the indictment of a crime involving dishonesty, breach of trust, physical harm to any person or serious moral turpitude; or

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

the engagement of conduct which is materially injurious to us (monetarily or otherwise) or which constitutes a material violation of federal or state law relating
to us or our business.

The term “good reason” included the occurrence any of the following without the
executive’s express consent:

 







  

a material adverse change to his overall status and responsibility;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

requiring him to be based at any place outside of fifty (50) miles from our current principal office;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

a reduction in his base salary or benefits; or

 







  

any failure by a successor company to assume and agree to perform our obligations hereunder.

STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%">Lisa Gopala

Ms. Gopala resigned
her employment with us effective May 21, 2008. Under the terms of an agreement that we entered into with Ms. Gopala at the time, we paid her a severance payment of $868,750, less applicable withholding amounts. In addition, the stock
options that Ms. Gopala received in connection with her employment agreement accelerated their vesting for an additional eighteen months following the termination date; however, she did not exercise any of such options prior to their expiration
date.

This excerpt taken from the ABII DEF 14A filed Oct 3, 2008.

PAYMENTS UPON TERMINATION

This section describes the payments and benefits that certain of our named executive officers would have been entitled to had their employment been terminated under the circumstances described below on December 31, 2007. In this section, the value associated with the acceleration of equity compensation is based on the closing market price of a share of our common stock as of December 31, 2007 minus the exercise price. On December 31, 2007, the closing market price of our common stock was $68.77. The amounts also include those amounts that the executive earned through that time and estimated amounts that would be paid out upon termination. The actual payments to the executive can only be determined at the actual time of termination.

Lisa Gopala

Under the terms of the old agreement that has since been terminated, if Ms. Gopala employment had been terminated by us without cause, by her for good reason, or she was terminated within 12 months following a change of control, she would have been entitled to receive (in addition to her salary up to the termination date

 

25


and post-termination benefits under company benefit plans) continuation of salary based on her then-current base salary and a bonus amount (calculated based on prior bonuses paid) for an eighteen month period after such termination. In addition, the vesting of the stock options that Ms. Gopala received in connection with her employment agreement would have accelerated for an additional eighteen months following the termination date.

For purposes of this agreement, the term “cause” included:

 

   

a material breach of the agreement;

 

   

the failure of the executive to substantially perform her duties which continues for 20 days following notice;

 

   

the commission of a crime involving dishonesty or moral turpitude, gross negligence or willful misconduct in the performance of duties; or

 

   

she engages in conduct that is materially injurious to the company.

The term “good reason” included the occurrence any of the following without her express consent:

 

   

a material adverse change to her overall status and responsibility in our company;

 

   

she is required to be based at any place outside of fifty (50) miles from our current principal office;

 

   

a reduction in her base salary or benefits; or

 

   

any failure by the successor to the company to assume and agree to perform the company’s obligations hereunder.

The term “change of control” included a transaction in which either our stockholders immediately prior to such transaction ceased to hold more than fifty percent (50%) of our voting capital stock or we sold substantially all of our assets to a third party.

Our obligations to make the continuing payments and the acceleration of the vesting of her options were conditioned upon Ms. Gopala agreeing not to compete with our business for a period of eighteen months following the termination date and agreeing not to solicit our employees to be employed by any competitor during that period. If Ms. Gopala failed to perform these covenants, then we would have been entitled to cease making the continuation payments in addition to other rights that we may have.

If Ms. Gopala had been terminated by us without cause, by her for good reason, or if a change of control had occurred and she had been terminated as of December 31, 2007, she would have been entitled to an amount of payments totaling $1,139,154. This amount is comprised of $675,000 representing payments of her base salary for the eighteen months following the termination date, $100,000 as the bonus amount, plus $239,154 representing the excess of the fair market value of the options that would have vested as result of the termination over the option exercise price.

Ms. Gopala resigned her employment with us effective May 21, 2008. Under the terms of an agreement that we entered into with Ms. Gopala at the time, we paid her the amounts that she would have been entitled to receive in connection with a termination of her employment without cause. In addition, the stock options that Ms. Gopala received in connection with her employment agreement accelerated for an additional eighteen months following the termination date.

Carlo Montagner

Under the terms of the old agreement that has since been terminated, if Mr. Montagner’s employment had been terminated by us without cause as of December 31, 2007, he would have been entitled to receive (in addition to his salary up to the termination date and post-termination benefits under company benefit plans) continuation of salary based on his then-current base salary and a bonus calculated based on prior bonuses paid

 

26


for a twenty-four month period after such termination. In addition, the vesting of the stock options that Mr. Montagner received in connection with his employment agreement would have accelerated for an additional twenty-four months following the termination date.

For purposes of this old agreement, the term “cause” includes:

 

   

a material breach of the agreement;

 

   

the failure of the executive to substantially perform his duties which continues for 20 days following notice;

 

   

the commission of a crime involving dishonesty or moral turpitude, gross negligence or willful misconduct in the performance of duties; or

 

   

he engages in conduct that is materially injurious to the company.

Our obligations to make the continuing payments and the acceleration of vesting of his options would have been conditioned upon Mr. Montagner agreeing not to compete with our business for a period of two years following the termination date and agreeing not to solicit our employees to be employed by any competitor during that period. If Mr. Montagner fails to perform these covenants, then we would have been entitled to cease making the continuation payments in addition to other rights that we may have had.

Effective February 6, 2008, Mr. Montagner entered into a new employment agreement with Abraxis Australia that supersedes his prior employment agreement with us. Under the terms of his new employment agreement, if Mr. Montagner’s employment is terminated without cause, he would be entitled to receive continuation of salary based on his then-current base salary through the end of the term of the agreement. In addition, the vesting of any stock options that Mr. Montagner holds would accelerate through the end of the term of the agreement. If Mr. Montagner accepts the continuing payments and the acceleration of vesting of his options, he will agree not to compete with the company’s business, subject to limited specified exceptions, for a period of three years following the termination date and agree not to solicit employees to be employed by any competitor during that period.

If Mr. Montagner had been terminated by us without cause as of December 31, 2007, he would have been entitled to an amount of payments totaling $1,687,500 under the old agreement. This amount would have been comprised of $1,350,000 representing payments of his base salary for two years following the termination date and an estimated amount of $337,500 as the bonus amount. If Mr. Montagner had been terminated as of December 31, 2007 under the terms of his new employment agreement, he would have been entitled to receive payments totaling $712,500, consisting of his base salary through July 31, 2009. The exercise price of the accelerated options exceeded the closing price as of December 31, 2007, and therefore no value was attributed to those options.

These excerpts taken from the ABII 10-K filed May 5, 2008.

PAYMENTS UPON TERMINATION

This section describes the payments and benefits that certain of our named executive officers would have been entitled to had their employment been terminated under the circumstances described below on December 31, 2007. In this section, the value associated with the acceleration of equity compensation is based on the closing market price of a share of our common stock as of December 31, 2007 minus the exercise price. On December 31, 2007, the closing market price of our common stock was $68.77. The amounts also include those amounts that the executive earned through that time and estimated amounts that would be paid out upon termination. The actual payments to the executive can only be determined at the actual time of termination.

Lisa Gopala

If Ms. Gopala employment is terminated by us without cause, by her for good reason, or she is terminated within 12 months following a change of control, she would be entitled to receive (in addition to her salary up to the termination date and post-termination benefits under company benefit plans) continuation of salary based on her then-current base salary and a bonus amount (calculated based on prior bonuses paid) for an eighteen month period after such termination. In addition, the vesting of the stock options that Ms. Gopala received in connection with her employment agreement would accelerate for an additional eighteen months following the termination date.

For purposes of this agreement, the term “cause” includes:

 

   

a material breach of the agreement;

 

   

the failure of the executive to substantially perform her duties which continues for 20 days following notice;

 

   

the commission of a crime involving dishonesty or moral turpitude, gross negligence or willful misconduct in the performance of duties; or

 

   

she engages in conduct that is materially injurious to the company.

The term “good reason” includes the occurrence any of the following without her express consent:

 

   

a material adverse change to her overall status and responsibility in our company;

 

   

she is required to be based at any place outside of fifty (50) miles from our current principal office;

 

   

a reduction in her base salary or benefits; or

 

   

any failure by the successor to the company to assume and agree to perform the company’s obligations hereunder.

The term “change of control” includes a transaction in which either our stockholders immediately prior to such transaction ceases to hold more than fifty percent (50%) of our voting capital stock or we sell substantially all of our assets to a third party.

Our obligations to make the continuing payments and the acceleration of the vesting of her options are conditioned upon Ms. Gopala agreeing not to compete with our business for a period of eighteen months following the termination date and agreeing not to solicit our employees to be employed by any competitor during that period. If Ms. Gopala fails to perform these covenants, then we are entitled to cease making the continuation payments in addition to other rights that we may have.

If Ms. Gopala had been terminated by us without cause, by her for good reason, or if a change of control had occurred and she had been terminated as of December 31, 2007, she would have been entitled to an amount of payments totaling $1,139,154. This amount is comprised of $675,000 representing payments of her base salary

 

22


for the eighteen months following the termination date, $225,000 as the bonus amount, plus $239,154 representing the excess of the fair market value of the options that would have vested as result of the termination over the option exercise price.

Carlo Montagner

Under the terms of the old agreement that has since been terminated, if Mr. Montagner’s employment had been terminated by us without cause as of December 31, 2007, he would have been entitled to receive (in addition to his salary up to the termination date and post-termination benefits under company benefit plans) continuation of salary based on his then-current base salary and a bonus calculated based on prior bonuses paid for a twenty-four month period after such termination. In addition, the vesting of the stock option that Mr. Montagner received in connection with his employment agreement would have accelerated for an additional twenty-four months following the termination date.

For purposes of this old agreement, the term “cause” includes:

 

   

a material breach of the agreement;

 

   

the failure of the executive to substantially perform his duties which continues for 20 days following notice;

 

   

the commission of a crime involving dishonesty or moral turpitude, gross negligence or willful misconduct in the performance of duties; or

 

   

he engages in conduct that is materially injurious to the company.

Our obligations to make the continuing payments and the acceleration of vesting of his options would have been conditioned upon Mr. Montagner agreeing not to compete with our business for a period of two years following the termination date and agreeing not to solicit our employees to be employed by any competitor during that period. If Mr. Montagner fails to perform these covenants, then we would have been entitled to cease making the continuation payments in addition to other rights that we may have had.

Effective February 6, 2008, Mr. Montagner entered into a new employment agreement with Abraxis Australia that supersedes his prior employment agreement with us. Under the terms of his new employment agreement, if Mr. Montagner’s employment is terminated without cause, he would be entitled to receive continuation of salary based on his then-current base salary through the end of the term of the agreement. In addition, the vesting of any stock options that Mr. Montagner holds would accelerate through the end of the term of the agreement. If Mr. Montagner accepts the continuing payments and the acceleration of vesting of his options, he will agree not to compete with the company’s business, subject to limited specified exceptions, for a period of three years following the termination date and agree not to solicit employees to be employed by any competitor during that period.

If Mr. Montagner had been terminated by us without cause as of December 31, 2007, he would have been entitled to an amount of payments totaling $1,687,500 under the old agreement. This amount would have been comprised of $1,350,000 representing payments of his base salary for two years following the termination date and an estimated amount of $337,500 as the bonus amount. If Mr. Montagner had been terminated as of December 31, 2007 under the terms of his new employment agreement, he would have been entitled to receive payments totaling $712,500, consisting of his base salary through July 31, 2009. The exercise price of the accelerated options exceeded the closing price as of December 31, 2007, and therefore no value was attributed to those options.

 

23


PAYMENTS UPON TERMINATION

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">This section describes the payments and benefits that certain of our named executive officers would have been entitled to had their employment been
terminated under the circumstances described below on December 31, 2007. In this section, the value associated with the acceleration of equity compensation is based on the closing market price of a share of our common stock as of
December 31, 2007 minus the exercise price. On December 31, 2007, the closing market price of our common stock was $68.77. The amounts also include those amounts that the executive earned through that time and estimated amounts that would
be paid out upon termination. The actual payments to the executive can only be determined at the actual time of termination.

Lisa
Gopala

If Ms. Gopala employment is terminated by us without cause, by her for good reason, or she is terminated within 12 months
following a change of control, she would be entitled to receive (in addition to her salary up to the termination date and post-termination benefits under company benefit plans) continuation of salary based on her then-current base salary and a bonus
amount (calculated based on prior bonuses paid) for an eighteen month period after such termination. In addition, the vesting of the stock options that Ms. Gopala received in connection with her employment agreement would accelerate for an
additional eighteen months following the termination date.

For purposes of this agreement, the term “cause” includes:

 







  

a material breach of the agreement;

 







  

the failure of the executive to substantially perform her duties which continues for 20 days following notice;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

the commission of a crime involving dishonesty or moral turpitude, gross negligence or willful misconduct in the performance of duties; or

 







  

she engages in conduct that is materially injurious to the company.

FACE="Times New Roman" SIZE="2">The term “good reason” includes the occurrence any of the following without her express consent:

 







  

a material adverse change to her overall status and responsibility in our company;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

she is required to be based at any place outside of fifty (50) miles from our current principal office;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

a reduction in her base salary or benefits; or

 







  

any failure by the successor to the company to assume and agree to perform the company’s obligations hereunder.

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">The term “change of control” includes a transaction in which either our stockholders immediately prior to such transaction ceases to hold more
than fifty percent (50%) of our voting capital stock or we sell substantially all of our assets to a third party.

Our obligations to
make the continuing payments and the acceleration of the vesting of her options are conditioned upon Ms. Gopala agreeing not to compete with our business for a period of eighteen months following the termination date and agreeing not to solicit
our employees to be employed by any competitor during that period. If Ms. Gopala fails to perform these covenants, then we are entitled to cease making the continuation payments in addition to other rights that we may have.

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">If Ms. Gopala had been terminated by us without cause, by her for good reason, or if a change of control had occurred and she had been terminated as
of December 31, 2007, she would have been entitled to an amount of payments totaling $1,139,154. This amount is comprised of $675,000 representing payments of her base salary

 


22









for the eighteen months following the termination date, $225,000 as the bonus amount, plus $239,154 representing the excess of the fair market value of the
options that would have vested as result of the termination over the option exercise price.

Carlo Montagner

STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%">Under the terms of the old agreement that has since been terminated, if Mr. Montagner’s employment had been terminated by us without cause as of
December 31, 2007, he would have been entitled to receive (in addition to his salary up to the termination date and post-termination benefits under company benefit plans) continuation of salary based on his then-current base salary and a bonus
calculated based on prior bonuses paid for a twenty-four month period after such termination. In addition, the vesting of the stock option that Mr. Montagner received in connection with his employment agreement would have accelerated for an
additional twenty-four months following the termination date.

For purposes of this old agreement, the term “cause” includes:

 







  

a material breach of the agreement;

 







  

the failure of the executive to substantially perform his duties which continues for 20 days following notice;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

the commission of a crime involving dishonesty or moral turpitude, gross negligence or willful misconduct in the performance of duties; or

 







  

he engages in conduct that is materially injurious to the company.

FACE="Times New Roman" SIZE="2">Our obligations to make the continuing payments and the acceleration of vesting of his options would have been conditioned upon Mr. Montagner agreeing not to compete with our business for a period of two years
following the termination date and agreeing not to solicit our employees to be employed by any competitor during that period. If Mr. Montagner fails to perform these covenants, then we would have been entitled to cease making the continuation
payments in addition to other rights that we may have had.

Effective February 6, 2008, Mr. Montagner entered into a new
employment agreement with Abraxis Australia that supersedes his prior employment agreement with us. Under the terms of his new employment agreement, if Mr. Montagner’s employment is terminated without cause, he would be entitled to receive
continuation of salary based on his then-current base salary through the end of the term of the agreement. In addition, the vesting of any stock options that Mr. Montagner holds would accelerate through the end of the term of the agreement. If
Mr. Montagner accepts the continuing payments and the acceleration of vesting of his options, he will agree not to compete with the company’s business, subject to limited specified exceptions, for a period of three years following the
termination date and agree not to solicit employees to be employed by any competitor during that period.

If Mr. Montagner had been
terminated by us without cause as of December 31, 2007, he would have been entitled to an amount of payments totaling $1,687,500 under the old agreement. This amount would have been comprised of $1,350,000 representing payments of his base
salary for two years following the termination date and an estimated amount of $337,500 as the bonus amount. If Mr. Montagner had been terminated as of December 31, 2007 under the terms of his new employment agreement, he would have been
entitled to receive payments totaling $712,500, consisting of his base salary through July 31, 2009. The exercise price of the accelerated options exceeded the closing price as of December 31, 2007, and therefore no value was attributed to
those options.

 


23








This excerpt taken from the ABII 8-K filed Nov 8, 2007.

Payments upon Termination

This section describes the payments and benefits that certain of our NEOs would have been entitled to had their employment been terminated under the circumstances described below on December 31, 2006. In this section, the value associated with the acceleration of equity compensation is based on the closing market price of a share of our common stock as of December 29, 2006 (the last trading day in 2006) minus the exercise price. On December 29, 2006, the closing market price of our common stock was $27.34. The amounts also include those amounts that the executive earned through that time and estimated amounts that would be paid out upon termination. The actual payments to the executive can only be determined at the actual time of termination.

Lisa Gopala

If Ms. Gopala employment is terminated by us without cause, by her for good reason, or she is terminated within 12 months following a change of control, she would be entitled to receive (in addition to her salary up to the termination date and post-termination benefits under company benefit plans) continuation of salary based on her then-current base salary and a bonus amount (calculated based on prior bonuses paid) for an eighteen month period after such termination. In addition, the vesting of the stock options that Ms. Gopala received in connection with her employment agreement would accelerate for an additional eighteen months following the termination date.

Our obligations to make the continuing payments and the acceleration of the vesting of her options are conditioned upon Ms. Gopala agreeing not to compete with our business for a period of eighteen months following the termination date and agreeing not to solicit our employees to be employed by any competitor during that period. If Ms. Gopala fails to perform these covenants, then we are entitled to cease making the continuation payments in addition to other rights that we may have.

If Ms. Gopala had been terminated by Abraxis BioScience without cause, by her for good reason, or if a change of control had occurred and she had been terminated as of December 31, 2006, she would have been entitled to an amount of payments totaling $810,558. This amount is comprised of $600,000 representing payments of her base salary for the eighteen months following the termination date, $83,333 as the bonus amount, plus $127,225 representing the excess of the fair market value of the options that would have vested as result of the termination over the option exercise price.

Carlo Montagner

If Mr. Montagner’s employment is terminated by us without cause, he would be entitled to receive (in addition to his salary up to the termination date and post-termination benefits under company benefit plans) continuation of salary based on his then-current base salary and a bonus calculated based on prior bonuses paid) for a twenty-four month period after such termination. In addition, the vesting of the stock option that Mr. Montagner received in connection with his employment agreement would accelerate for an additional twenty-four months following the termination date.

Our obligations to make the continuing payments and the acceleration of vesting of his options is conditioned upon Mr. Montagner agreeing not to compete with our business for a period of two years following the termination date and agreeing not to solicit our employees to be employed by any competitor during that period. If Mr. Montagner fails to perform these covenants, then we are entitled to cease making the continuation payments in addition to other rights that we may have.

If Mr. Montagner had been terminated by Abraxis BioScience without cause as of December 31, 2006, he would have been entitled to an estimated amount of payments totaling $1,687,500. This amount is comprised of $1,350,000 representing payments of his base salary for two years following the termination date and his target bonus amount of $337,500. The exercise price of the accelerated options exceeded the closing price as of December 29, 2006, and therefore no value was attributed to those options.

 

119


Table of Contents

"PAYMENTS UPON TERMINATION" elsewhere:

Adherex Technologies (ADH)
ATS Medical (ATSI)
Diversa (DVSA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki